Industry Trend Analysis - Acquisition Will Bolster Aurobindo's Performance In Underdeveloped European Market - MAR 2017
Western Europe February 2017 / Portugal / Industry
This acquisition will provide Aurobindo Pharma with another revenue stream in Europe, boosting its sales in what remains an underdeveloped region for the firm. As a market, Europe will still lag...
Industry Trend Analysis - Expanding By Acquisitions Will Support Shire's Strategical Shift - AUG 2016
Western Europe July 2016 / Ireland / Industry
Shire's Q116 results emphasise the importance of its core revenue-generators as the company focuses on its strategic shift towards rare disorders, immunology and oncology. Shire's strategy of...
Industry Trend Analysis - Meda Acquisition Will Expand Mylan's Product And Regional Outlook - MAY 2016
Western Europe April 2016 / Sweden / Industry
Mylan's unsuccessful attempt to acquire Perrigo revealed the company's interest in building up an OTC presence, a strategy Mylan is returning to through these plans to acquire Meda. Unlike Mylan...
Industry Trend Analysis - Acquisition Battles Dominated Generic Industry In 2015 And Will Shape It In 2016 - MAR 2016
Western Europe February 2016 / Global / Industry
Merger and acquisition activity within the global generic industry in 2015 highlighted ongoing trends for consolidation amongst generic and branded manufacturers. The year was shaped by M&...
Industry Trend Analysis - Mylan's European Generic Sales On Course To Dominate In FY16 - NOV 2015
Western Europe October 2015 / Netherlands / Industry
Reflecting the results of the acquisition of Abbott's non-US generics businesses, Mylan's non-North America generic sales outstripped North American sales for the first time. The rate by which...
Industry Trend Analysis - Omega Acquisition Will Establish Perrigo's OTC Dominance - JULY 2015
Western Europe June 2015 / Belgium / Industry
Perrigo has developed a business model that uses the OTC market in large part, and this acquisition will continue to develop that business strand. The lower prices associated with OTC products...
Industry Trend Analysis - Novartis Under Pressure To Maximise Revenue Growth Of GSK's Oncology Portfolio - JUNE 2015
Western Europe May 2015 / Switzerland / Industry
Novartis can maximise revenue from GlaxoSmithKline's cancer products further than the efforts of GSK. There is pressure for Novartis to do this in order to recoup from the costly transaction. Not...
Industry Trend Analysis - GSK Strengthens Early Stage Vaccine Pipeline With GlycoVaxyn Acquisition - MAY 2015
Western Europe April 2015 / Switzerland / Industry
GlaxoSmithKline's focus on vaccines will be a large contributor to the company's growth in emerging markets. The Novartis transaction will add breadth its vaccine portfolio and the GlycoVaxyn...
Industry Trend Analysis - Actavis' First Acquisition Of 2015 Will Boost Its UK Generics Presence - APR 2015
Western Europe March 2015 / United Kingdom / Industry
This is the first newly-announced Actavis acquisition of 2015 and something of a change of focus for the firm. Many of the acquisitions announced in 2014 concentrated both on the US market and on...
Industry Trend Analysis - AstraZeneca Fast-Tracks Into Up-And-Coming LABA/LAMA Market - FEB 2015
Western Europe January 2015 / United Kingdom / Industry
The strategic acquisition of Almirall's respiratory business unit will propel AstraZeneca into the up-and-coming LABA/LAMA market for the treatment of chronic obstructive pulmonary disease, driven...